FDA limits Elevidys gene therapy to ambulatory Duchenne patients – Fierce Pharma

(Sarah Silbiger/Stringer/Getty Images News). The FDA has officially limited the label of Sarepta Therapeutics’ Elevidys, putting an end to a …